This report provides a comprehensive analysis of the global vascular guidewires market, projecting steady growth through 2032. Driven by an aging global population and rising healthcare expenditures, the market is increasingly shaped by the demand for interventional procedures like PTCA. The study offers detailed segmentation by material, length, diameter, and application, while evaluating key regional trends and competitive strategies. It serves as a vital resource for understanding market dynamics, technological advancements, and emerging opportunities across the medical device landscape.

Market Overview

The global Vascular Guidewires market size is predicted to grow from US$ 1938 million in 2025 to US$ 2772 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Vascular guidewires are utilized in interventional procedures to guide catheters to specific target sites for treatment. Percutaneous transluminal coronary angioplasty (PTCA) is the most widely used procedure in which guidewires are extensively employed, followed by angioplasty.

Market Drivers and Economic Context

Demographic and Health Trends

• Aging Population: The growing older population is a major contributor to market growth. The WHO estimates that approximately two billion people will be aged 60 and above by 2050. The older adult population is more susceptible to chronic diseases, necessitating frequent care at healthcare facilities.
• Disease Prevalence: The growing prevalence of chronic and infectious diseases is driving market needs.

Healthcare Expenditure and Industry Dynamics

• Global Healthcare Spending: Healthcare spending accounts for 10% of the global GDP and has been continuously rising in recent years due to increasing health needs of the aging population, the prevalence of diseases, and the expansion of emerging markets.
• Medical Device Role: The medical devices market plays a significant role within the healthcare industry.
• Key Growth Drivers:
• Increasing demand for advanced healthcare services globally.
• Advancements in medical technology.
• Growing geriatric population.
• Rising healthcare expenditure.
• Increasing awareness regarding early disease diagnosis and treatment.

Report Scope and Methodology

Produced by LP Information, Inc. (LPI), the “Vascular Guidewires Industry Forecast” reviews total world Vascular Guidewires sales in 2025 and provides a comprehensive analysis of projected sales from 2026 through 2032.

This Insight Report offers:

• Detailed Analysis: A breakdown in US$ millions by region, market sector, and sub-sector.
• Landscape Analysis: Highlights regarding product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Insights: Analysis of leading global companies focusing on their Vascular Guidewires portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Forecast Depth: Evaluation of key market trends, drivers, and affecting factors, with breakdowns by Material, Application, geography, and market size to identify emerging pockets of opportunity.
• Methodology: A transparent approach based on hundreds of bottom-up qualitative and quantitative market inputs to provide a nuanced view of the current state and future trajectory of the global market.

Market Segmentation

By Material

• Nitinol Vascular Guidewires
• Stainless Steel Vascular Guidewires
• Others

By Length

• 2.6m
• 3m
• 1.5m
• 1.8m
• Other

By Diameter

• 0.035"
• 0.018"
• Other

By Application

• Angled
• J Shape
• Straight

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of company coverage, product portfolio, and market penetration:

• Terumo Medical
• Abbott
• Asahi Intecc
• Boston Scientific Corporation
• Cook Medical
• TE Connectivity
• Merit
• SP Medical
• Integer
• Medtronic
• Cordis
• Infiniti Medical
• EPflex
• (SCS) Shannon Coiled Springs
• Acme Monaco
• Custom Wire Technologies
• Biotronik
• Furukawa
• TRS
• FMD
• Biomerics
• Heraeus Medevio
• B. Braun
• Yokowo
• APT Medical
• Hanaco
• Lepu Meidcal
• SCW Medicath
• BrosMed
• Demax Medical

Key Questions Addressed

• What is the 10-year outlook for the global Vascular Guidewires market?
• What factors are driving Vascular Guidewires market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Vascular Guidewires market opportunities vary by end market size?
• How does Vascular Guidewires break out by Material and Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Vascular Guidewires Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Vascular Guidewires by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Vascular Guidewires by Country/Region, 2021, 2025 & 2032

  • 2.2 Vascular Guidewires Segment by Material

    • 2.2.1 Nitinol Vascular Guidewires

    • 2.2.2 Stainless Steel Vascular Guidewires

    • 2.2.3 Others

    • 2.2.4 Vascular Guidewires Sales by Material

      • 2.2.4.1 Global Vascular Guidewires Sales Market Share by Material (2021-2026)
      • 2.2.4.2 Global Vascular Guidewires Revenue and Market Share by Material (2021-2026)
      • 2.2.4.3 Global Vascular Guidewires Sale Price by Material (2021-2026)

  • 2.3 Vascular Guidewires Segment by Length

    • 2.3.1 2.6m

    • 2.3.2 3m

    • 2.3.3 1.5m

    • 2.3.4 1.8m

    • 2.3.5 Other

    • 2.3.6 Vascular Guidewires Sales by Length

      • 2.3.6.1 Global Vascular Guidewires Sales Market Share by Length (2021-2026)
      • 2.3.6.2 Global Vascular Guidewires Revenue and Market Share by Length (2021-2026)
      • 2.3.6.3 Global Vascular Guidewires Sale Price by Length (2021-2026)

  • 2.4 Vascular Guidewires Segment by Diameter

    • 2.4.1 0.035"

    • 2.4.2 0.018"

    • 2.4.3 Other

    • 2.4.4 Vascular Guidewires Sales by Diameter

      • 2.4.4.1 Global Vascular Guidewires Sales Market Share by Diameter (2021-2026)
      • 2.4.4.2 Global Vascular Guidewires Revenue and Market Share by Diameter (2021-2026)
      • 2.4.4.3 Global Vascular Guidewires Sale Price by Diameter (2021-2026)

  • 2.5 Vascular Guidewires Segment by Application

    • 2.5.1 Angled

    • 2.5.2 J Shape

    • 2.5.3 Straight

    • 2.5.4 Vascular Guidewires Sales by Application

      • 2.5.4.1 Global Vascular Guidewires Sale Market Share by Application (2021-2026)
      • 2.5.4.2 Global Vascular Guidewires Revenue and Market Share by Application (2021-2026)
      • 2.5.4.3 Global Vascular Guidewires Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Vascular Guidewires Breakdown Data by Company

    • 3.1.1 Global Vascular Guidewires Annual Sales by Company (2021-2026)

    • 3.1.2 Global Vascular Guidewires Sales Market Share by Company (2021-2026)

  • 3.2 Global Vascular Guidewires Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Vascular Guidewires Revenue by Company (2021-2026)

    • 3.2.2 Global Vascular Guidewires Revenue Market Share by Company (2021-2026)

  • 3.3 Global Vascular Guidewires Sale Price by Company

  • 3.4 Key Manufacturers Vascular Guidewires Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Vascular Guidewires Product Location Distribution

    • 3.4.2 Players Vascular Guidewires Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Vascular Guidewires by Geographic Region

  • 4.1 World Historic Vascular Guidewires Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Vascular Guidewires Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Vascular Guidewires Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Vascular Guidewires Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Vascular Guidewires Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Vascular Guidewires Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Vascular Guidewires Sales Growth

  • 4.4 APAC Vascular Guidewires Sales Growth

  • 4.5 Europe Vascular Guidewires Sales Growth

  • 4.6 Middle East & Africa Vascular Guidewires Sales Growth

• 5 Americas

  • 5.1 Americas Vascular Guidewires Sales by Country

    • 5.1.1 Americas Vascular Guidewires Sales by Country (2021-2026)

    • 5.1.2 Americas Vascular Guidewires Revenue by Country (2021-2026)

  • 5.2 Americas Vascular Guidewires Sales by Material (2021-2026)

  • 5.3 Americas Vascular Guidewires Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Vascular Guidewires Sales by Region

    • 6.1.1 APAC Vascular Guidewires Sales by Region (2021-2026)

    • 6.1.2 APAC Vascular Guidewires Revenue by Region (2021-2026)

  • 6.2 APAC Vascular Guidewires Sales by Material (2021-2026)

  • 6.3 APAC Vascular Guidewires Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Vascular Guidewires by Country

    • 7.1.1 Europe Vascular Guidewires Sales by Country (2021-2026)

    • 7.1.2 Europe Vascular Guidewires Revenue by Country (2021-2026)

  • 7.2 Europe Vascular Guidewires Sales by Material (2021-2026)

  • 7.3 Europe Vascular Guidewires Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Vascular Guidewires by Country

    • 8.1.1 Middle East & Africa Vascular Guidewires Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Vascular Guidewires Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Vascular Guidewires Sales by Material (2021-2026)

  • 8.3 Middle East & Africa Vascular Guidewires Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Vascular Guidewires

  • 10.3 Manufacturing Process Analysis of Vascular Guidewires

  • 10.4 Industry Chain Structure of Vascular Guidewires

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Vascular Guidewires Distributors

  • 11.3 Vascular Guidewires Customer

• 12 World Forecast Review for Vascular Guidewires by Geographic Region

  • 12.1 Global Vascular Guidewires Market Size Forecast by Region

    • 12.1.1 Global Vascular Guidewires Forecast by Region (2027-2032)

    • 12.1.2 Global Vascular Guidewires Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Vascular Guidewires Forecast by Material (2027-2032)

  • 12.7 Global Vascular Guidewires Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Terumo Medical

    • 13.1.1 Terumo Medical Company Information

    • 13.1.2 Terumo Medical Vascular Guidewires Product Portfolios and Specifications

    • 13.1.3 Terumo Medical Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Terumo Medical Main Business Overview

    • 13.1.5 Terumo Medical Latest Developments

  • 13.2 Abbott

    • 13.2.1 Abbott Company Information

    • 13.2.2 Abbott Vascular Guidewires Product Portfolios and Specifications

    • 13.2.3 Abbott Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Abbott Main Business Overview

    • 13.2.5 Abbott Latest Developments

  • 13.3 Asahi Intecc

    • 13.3.1 Asahi Intecc Company Information

    • 13.3.2 Asahi Intecc Vascular Guidewires Product Portfolios and Specifications

    • 13.3.3 Asahi Intecc Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Asahi Intecc Main Business Overview

    • 13.3.5 Asahi Intecc Latest Developments

  • 13.4 Boston Scientific Corporation

    • 13.4.1 Boston Scientific Corporation Company Information

    • 13.4.2 Boston Scientific Corporation Vascular Guidewires Product Portfolios and Specifications

    • 13.4.3 Boston Scientific Corporation Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Boston Scientific Corporation Main Business Overview

    • 13.4.5 Boston Scientific Corporation Latest Developments

  • 13.5 Cook Medical

    • 13.5.1 Cook Medical Company Information

    • 13.5.2 Cook Medical Vascular Guidewires Product Portfolios and Specifications

    • 13.5.3 Cook Medical Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Cook Medical Main Business Overview

    • 13.5.5 Cook Medical Latest Developments

  • 13.6 TE Connectivity

    • 13.6.1 TE Connectivity Company Information

    • 13.6.2 TE Connectivity Vascular Guidewires Product Portfolios and Specifications

    • 13.6.3 TE Connectivity Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 TE Connectivity Main Business Overview

    • 13.6.5 TE Connectivity Latest Developments

  • 13.7 Merit

    • 13.7.1 Merit Company Information

    • 13.7.2 Merit Vascular Guidewires Product Portfolios and Specifications

    • 13.7.3 Merit Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Merit Main Business Overview

    • 13.7.5 Merit Latest Developments

  • 13.8 SP Medical

    • 13.8.1 SP Medical Company Information

    • 13.8.2 SP Medical Vascular Guidewires Product Portfolios and Specifications

    • 13.8.3 SP Medical Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 SP Medical Main Business Overview

    • 13.8.5 SP Medical Latest Developments

  • 13.9 Integer

    • 13.9.1 Integer Company Information

    • 13.9.2 Integer Vascular Guidewires Product Portfolios and Specifications

    • 13.9.3 Integer Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Integer Main Business Overview

    • 13.9.5 Integer Latest Developments

  • 13.10 Medtronic

    • 13.10.1 Medtronic Company Information

    • 13.10.2 Medtronic Vascular Guidewires Product Portfolios and Specifications

    • 13.10.3 Medtronic Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Medtronic Main Business Overview

    • 13.10.5 Medtronic Latest Developments

  • 13.11 Cordis

    • 13.11.1 Cordis Company Information

    • 13.11.2 Cordis Vascular Guidewires Product Portfolios and Specifications

    • 13.11.3 Cordis Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Cordis Main Business Overview

    • 13.11.5 Cordis Latest Developments

  • 13.12 Infiniti Medical

    • 13.12.1 Infiniti Medical Company Information

    • 13.12.2 Infiniti Medical Vascular Guidewires Product Portfolios and Specifications

    • 13.12.3 Infiniti Medical Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Infiniti Medical Main Business Overview

    • 13.12.5 Infiniti Medical Latest Developments

  • 13.13 EPflex

    • 13.13.1 EPflex Company Information

    • 13.13.2 EPflex Vascular Guidewires Product Portfolios and Specifications

    • 13.13.3 EPflex Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 EPflex Main Business Overview

    • 13.13.5 EPflex Latest Developments

  • 13.14 (SCS) Shannon Coiled Springs

    • 13.14.1 (SCS) Shannon Coiled Springs Company Information

    • 13.14.2 (SCS) Shannon Coiled Springs Vascular Guidewires Product Portfolios and Specifications

    • 13.14.3 (SCS) Shannon Coiled Springs Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 (SCS) Shannon Coiled Springs Main Business Overview

    • 13.14.5 (SCS) Shannon Coiled Springs Latest Developments

  • 13.15 Acme Monaco

    • 13.15.1 Acme Monaco Company Information

    • 13.15.2 Acme Monaco Vascular Guidewires Product Portfolios and Specifications

    • 13.15.3 Acme Monaco Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Acme Monaco Main Business Overview

    • 13.15.5 Acme Monaco Latest Developments

  • 13.16 Custom Wire Technologies

    • 13.16.1 Custom Wire Technologies Company Information

    • 13.16.2 Custom Wire Technologies Vascular Guidewires Product Portfolios and Specifications

    • 13.16.3 Custom Wire Technologies Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Custom Wire Technologies Main Business Overview

    • 13.16.5 Custom Wire Technologies Latest Developments

  • 13.17 Biotronik

    • 13.17.1 Biotronik Company Information

    • 13.17.2 Biotronik Vascular Guidewires Product Portfolios and Specifications

    • 13.17.3 Biotronik Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Biotronik Main Business Overview

    • 13.17.5 Biotronik Latest Developments

  • 13.18 Furukawa

    • 13.18.1 Furukawa Company Information

    • 13.18.2 Furukawa Vascular Guidewires Product Portfolios and Specifications

    • 13.18.3 Furukawa Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 Furukawa Main Business Overview

    • 13.18.5 Furukawa Latest Developments

  • 13.19 TRS

    • 13.19.1 TRS Company Information

    • 13.19.2 TRS Vascular Guidewires Product Portfolios and Specifications

    • 13.19.3 TRS Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 TRS Main Business Overview

    • 13.19.5 TRS Latest Developments

  • 13.20 FMD

    • 13.20.1 FMD Company Information

    • 13.20.2 FMD Vascular Guidewires Product Portfolios and Specifications

    • 13.20.3 FMD Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.20.4 FMD Main Business Overview

    • 13.20.5 FMD Latest Developments

  • 13.21 Biomerics

    • 13.21.1 Biomerics Company Information

    • 13.21.2 Biomerics Vascular Guidewires Product Portfolios and Specifications

    • 13.21.3 Biomerics Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.21.4 Biomerics Main Business Overview

    • 13.21.5 Biomerics Latest Developments

  • 13.22 Heraeus Medevio

    • 13.22.1 Heraeus Medevio Company Information

    • 13.22.2 Heraeus Medevio Vascular Guidewires Product Portfolios and Specifications

    • 13.22.3 Heraeus Medevio Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.22.4 Heraeus Medevio Main Business Overview

    • 13.22.5 Heraeus Medevio Latest Developments

  • 13.23 B. Braun

    • 13.23.1 B. Braun Company Information

    • 13.23.2 B. Braun Vascular Guidewires Product Portfolios and Specifications

    • 13.23.3 B. Braun Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.23.4 B. Braun Main Business Overview

    • 13.23.5 B. Braun Latest Developments

  • 13.24 Yokowo

    • 13.24.1 Yokowo Company Information

    • 13.24.2 Yokowo Vascular Guidewires Product Portfolios and Specifications

    • 13.24.3 Yokowo Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.24.4 Yokowo Main Business Overview

    • 13.24.5 Yokowo Latest Developments

  • 13.25 APT Medical

    • 13.25.1 APT Medical Company Information

    • 13.25.2 APT Medical Vascular Guidewires Product Portfolios and Specifications

    • 13.25.3 APT Medical Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.25.4 APT Medical Main Business Overview

    • 13.25.5 APT Medical Latest Developments

  • 13.26 Hanaco

    • 13.26.1 Hanaco Company Information

    • 13.26.2 Hanaco Vascular Guidewires Product Portfolios and Specifications

    • 13.26.3 Hanaco Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.26.4 Hanaco Main Business Overview

    • 13.26.5 Hanaco Latest Developments

  • 13.27 Lepu Meidcal

    • 13.27.1 Lepu Meidcal Company Information

    • 13.27.2 Lepu Meidcal Vascular Guidewires Product Portfolios and Specifications

    • 13.27.3 Lepu Meidcal Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.27.4 Lepu Meidcal Main Business Overview

    • 13.27.5 Lepu Meidcal Latest Developments

  • 13.28 SCW Medicath

    • 13.28.1 SCW Medicath Company Information

    • 13.28.2 SCW Medicath Vascular Guidewires Product Portfolios and Specifications

    • 13.28.3 SCW Medicath Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.28.4 SCW Medicath Main Business Overview

    • 13.28.5 SCW Medicath Latest Developments

  • 13.29 BrosMed

    • 13.29.1 BrosMed Company Information

    • 13.29.2 BrosMed Vascular Guidewires Product Portfolios and Specifications

    • 13.29.3 BrosMed Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.29.4 BrosMed Main Business Overview

    • 13.29.5 BrosMed Latest Developments

  • 13.30 Demax Medical

    • 13.30.1 Demax Medical Company Information

    • 13.30.2 Demax Medical Vascular Guidewires Product Portfolios and Specifications

    • 13.30.3 Demax Medical Vascular Guidewires Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.30.4 Demax Medical Main Business Overview

    • 13.30.5 Demax Medical Latest Developments

• 14 Research Findings and Conclusion